Kura Oncology, Inc.
DE ˙ DB ˙ US50127T1097
7,56 EUR ↑0,24 (3,28%)
2026-06-05
PREȚUL ACȚIUNILOR
SecurityDE:KUR / Kura Oncology, Inc.
InstitutionBarclays Plc
Latest Disclosed Ownership394,605 shares
Latest Disclosed Value $ 4,099,945
Barclays Plc reports 4.70% increase in ownership of KUR / Kura Oncology, Inc.

On February 13, 2026 - Barclays Plc filed a 13F-HR form disclosing ownership of 394,605 shares of Kura Oncology, Inc. (DE:KUR) valued at $3,437,010 USD as of December 31, 2025. The entity filed a previous 13F-HR/A on March 31, 2026 disclosing 376,879 shares of Kura Oncology, Inc.. This represents a change in shares of 4.70% during the quarter. The current value of the position is $2,983,214 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-02-13 2025-12-31 13F KURA ONCOLOGY COM 50127T109 394,605 17,726 4.70 4,100 22.91 0.0010
2026-03-31 2025-09-30 13F/A-3 KURA ONCOLOGY COM 50127T109 376,879 -26,362 -6.54 3,335 43.38 0.0007
2026-03-19 2025-09-30 13F/A-2 KURA ONCOLOGY COM 50127T109 165,484 -237,757 3,234 0.0009
2025-11-12 2025-09-30 13F KURA ONCOLOGY COM 50127T109 376,879 -26,362 3,335 0.0007
2026-02-27 2025-06-30 13F/A-2 KURA ONCOLOGY COM 50127T109 403,241 209,267 107.88 2,327 81.72 0.0005
2025-08-14 2025-06-30 13F/A-1 KURA ONCOLOGY COM 50127T109 403,241 209,267 2 0.0005
2025-08-13 2025-06-30 13F KURA ONCOLOGY COM 50127T109 403,241 209,267 2 0.0002
2026-03-17 2025-03-31 13F/A-1 KURA ONCOLOGY COM 50127T109 193,974 -7,890 -3.91 1,280 -27.19 0.0004
2025-05-15 2025-03-31 13F KURA ONCOLOGY COM 50127T109 193,974 -7,890 1 0.0004
2026-03-19 2024-12-31 13F/A-1 KURA ONCOLOGY COM 50127T109 201,864 36,380 21.98 1,758 -45.62 0.0005
2025-02-13 2024-12-31 13F KURA ONCOLOGY COM 50127T109 201,864 36,380 2 0.0005
2026-03-31 2024-09-30 13F/A-2 KURA ONCOLOGY COM 50127T109 165,484 84,563 104.50 3,234 94.06 0.0009
2024-11-19 2024-09-30 13F/A-1 KURA ONCOLOGY COM 50127T109 165,484 84,563 3 0.0009
2024-11-15 2024-09-30 13F KURA ONCOLOGY COM 50127T109 165,484 84,563 3 0.0003
2026-03-23 2024-06-30 13F/A-1 KURA ONCOLOGY COM 50127T109 80,921 -22,991 -22.13 1,666 -24.82 0.0005
2024-08-14 2024-06-30 13F KURA ONCOLOGY COM 50127T109 80,921 -22,991 2 0.0005
2026-03-24 2024-03-31 13F/A-1 KURA ONCOLOGY COM 50127T109 103,912 -103,360 -49.87 2,216 -25.64 0.0008
2024-05-15 2024-03-31 13F KURA ONCOLOGY COM 50127T109 103,912 -103,360 2 0.0008
2026-03-25 2023-12-31 13F/A-1 KURA ONCOLOGY COM 50127T109 207,272 52,027 33.51 2,981 110.60 0.0011
2024-02-15 2023-12-31 13F KURA ONCOLOGY COM 50127T109 207,272 52,027 3 0.0011
2026-03-26 2023-09-30 13F/A-1 KURA ONCOLOGY COM 50127T109 155,245 32,978 26.97 1,416 9.44 0.0009
2023-11-07 2023-09-30 13F KURA ONCOLOGY COM 50127T109 155,245 32,978 1 0.0009
2026-03-30 2023-06-30 13F/A-2 KURA ONCOLOGY COM 50127T109 122,267 -104,848 -46.17 1,294 -53.44 0.0008
2023-09-20 2023-06-30 13F/A-1 KURA ONCOLOGY COM 50127T109 122,267 -104,848 1 0.0008
2023-08-03 2023-06-30 13F KURA ONCOLOGY COM 50127T109 122,267 -104,848 1 0.0008
2026-03-30 2023-03-31 13F/A-1 KURA ONCOLOGY COM 50127T109 227,115 41,066 22.07 2,778 20.32 0.0013
2023-05-04 2023-03-31 13F KURA ONCOLOGY COM 50127T109 227,115 41,066 3 0.0013
2026-03-30 2022-12-31 13F/A-1 KURA ONCOLOGY COM 50127T109 186,049 -44,493 -19.30 2,309 -26.71 0.0010
2023-02-13 2022-12-31 13F KURA ONCOLOGY COM 50127T109 186,049 -44,493 2 0.0010
2022-11-03 2022-09-30 13F KURA ONCOLOGY COM 50127T109 230,542 128,990 127.02 3,149 69.30 0.0034
2022-08-12 2022-06-30 13F KURA ONCOLOGY COM 50127T109 101,552 39,063 62.51 1,860 85.26 0.0011
2022-05-16 2022-03-31 13F KURA ONCOLOGY COM 50127T109 62,489 -63,157 -50.27 1,004 -42.95 0.0008
2022-02-23 2021-12-31 13F/A-1 KURA ONCOLOGY COM 50127T109 125,646 42,711 51.50 1,760 13.33 0.0007
2022-02-14 2021-12-31 13F KURA ONCOLOGY COM 50127T109 125,646 42,711 1,760 0.0002
2021-11-09 2021-09-30 13F KURA ONCOLOGY COM 50127T109 82,935 8,189 10.96 1,553 -0.38 0.0007
2021-08-13 2021-06-30 13F KURA ONCOLOGY COM 50127T109 74,746 -61,456 -45.12 1,559 -59.53 0.0007
2021-05-13 2021-03-31 13F KURA ONCOLOGY COM 50127T109 136,202 114,698 533.38 3,852 448.72 0.0021
2021-02-11 2020-12-31 13F KURA ONCOLOGY COM 50127T109 21,504 -98,642 -82.10 702 -80.93 0.0004
2020-11-12 2020-09-30 13F KURA ONCOLOGY COM 50127T109 120,146 34,868 40.89 3,681 164.82 0.0022
2020-08-12 2020-06-30 13F KURA ONCOLOGY COM 50127T109 85,278 49,130 135.91 1,390 286.11 0.0011
2020-05-13 2020-03-31 13F KURA ONCOLOGY COM 50127T109 36,148 923 2.62 360 -25.62 0.0003
2020-02-10 2019-12-31 13F KURA ONCOLOGY COM 50127T109 35,225 18,176 106.61 484 86.87 0.0003
2019-11-15 2019-09-30 13F/A-1 KURA ONCOLOGY COM 50127T109 17,049 -4,630 -21.36 259 -39.34 0.0002
2019-11-14 2019-09-30 13F KURA ONCOLOGY COM 50127T109 17,049 -4,630 259 59.8811
2019-08-14 2019-06-30 13F KURA ONCOLOGY COM 50127T109 21,679 13,683 171.12 427 221.05 0.0003
2019-05-15 2019-03-31 13F KURA ONCOLOGY COM 50127T109 7,996 7,996 133 0.0001
2019-02-14 2018-12-31 13F KURA ONCOLOGY COM 50127T109 0 -12,965 -100.00 0 -100.00
2018-11-14 2018-09-30 13F KURA ONCOLOGY COM 50127T109 12,965 7,285 128.26 228 121.36 0.0002
2018-08-14 2018-06-30 13F KURA ONCOLOGY COM 50127T109 5,680 -3,297 -36.73 103 -38.69 0.0001
2018-05-15 2018-03-31 13F KURA ONCOLOGY COM 50127T109 8,977 3,600 66.95 168 104.88 0.0001
2018-02-14 2017-12-31 13F KURA ONCOLOGY COM 50127T109 5,377 4,928 1,097.55 82 1,071.43 0.0001
2017-11-14 2017-09-30 13F KURA ONCOLOGY COM 50127T109 449 438 3,981.82 7 0.0000
2017-08-14 2017-06-30 13F KURA ONCOLOGY COM 50127T109 11 -6,789 -99.84 0 -100.00
2017-05-15 2017-03-31 13F KURA ONCOLOGY COM 50127T109 6,800 6,800 60 0.0001
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.